Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

There has been a considerable advance in our understanding of the biochemical mechanisms responsible for conferring anti-neoplastic drug resistance in breast cancer. These are described along with therapeutic strategies leading to their modulation.

Original publication

DOI

10.1016/S0960-9776(96)90029-6

Type

Conference paper

Publication Date

01/01/1996

Volume

5

Pages

293 - 297